Core Viewpoint - The company, Stone Four Pharmaceutical Group, announced its intention to bid for 14 specifications of 12 products in China's 11th national centralized drug procurement scheduled for October 27, 2025 [1] Product Summary - The products intended for bidding include: - Dihydrocodeine Injection (2ml: 0.3g) [1] - Formoterol Fumarate Inhalation Solution (2ml: 20μg) [1] - Fluvoxamine Maleate Tablets (100mg and 50mg) [1] - Chlorzoxazone Injection (8mg) [1] - Adrenaline Hydrochloride Injection (1ml: 1mg) [1] - Bromhexine Hydrochloride Injection (2ml: 4mg) [1] - Compound Electrolyte Injection (500ml) [1] - Compound Electrolyte Injection II (500ml and 1000ml) [1] - Nicorandil Tablets (5mg) [1] - Salbutamol Sulfate Injection (1ml: 0.5mg) [1] - Benidipine Hydrochloride Tablets (8mg) [1] - Sodium Bicarbonate Injection (50ml: 4.2g) [1]
石四药集团(02005.HK)全国药品集中采购拟中选结果：含二羟丙茶硷等12个品种